Research progress of plant‐derived natural alkaloids in central nervous system diseases
Phytotherapy Research · 2023-11 · 37 (11) · 4885-4907
DOI: 10.1002/ptr.7955 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2023-07-16. Written by Qingqing Zhang and 6 co-authors. Institution: Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, She…. Major MEDLINE topics: Alkaloids, Alzheimer Disease, Plants, Medicinal, Central Nervous System Diseases. Cited 22 times so far (Crossref); 185 references. Funded by: National Natural Science Foundation of China, Shenyang Young and Middle-aged Innovative Talents Support Program, the Joint National Local Engineering Research Center of Fujian and Taiwan Chinese Medicine Molecular Biotechnology.
Abstract (original language)
Central nervous system (CNS) disease is one of the most important causes of human death. Because of their complex pathogenesis, more and more attention has been paid to them. At present, drug treatment of the CNS is the main means; however, most drugs only relieve symptoms, and some have certain toxicity and side effects. Natural compounds derived from plants can provide safer and more effective alternatives. Alkaloids are common nitrogenous basic organic compounds found in nature, which exist widely in many kinds of plants and have unique application value in modern medicine. For example, Galantamine and Huperzine A from medicinal plants are widely used drugs on the market to treat Alzheimer's disease. Therefore, the main purpose of this review is to provide the available information on natural alkaloids with the activity of treating central nervous system diseases in order to explore the trends and perspectives for the further study of central nervous system drugs. In this paper, 120 alkaloids with the potential effect of treating central nervous system diseases are summarized from the aspects of sources, structure types, mechanism of action and structure–activity relationship.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
- Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.
- College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
ORCID profiles: Lixia Chen
Funding
- National Natural Science Foundation of China
- Shenyang Young and Middle-aged Innovative Talents Support Program
- the Joint National Local Engineering Research Center of Fujian and Taiwan Chinese Medicine Molecular Biotechnology
- Fujian Key Laboratory of Chinese Materia Medica
- Fujian University Key Laboratory for Research and Development of TCM Resources
- Fujian University of Traditional Chinese Medicine
- Chuihui Program-Cooperative Research Project of the Ministry of Education
- Liaoning Province Natural Science Foundation
Cite
APA
Zhang, Q., Jiang, Q., Sa, K., Liang, J., Sun, D., Li, H., & Chen, L. (2023). Research progress of plant‐derived natural alkaloids in central nervous system diseases. Phytotherapy Research, 37(11), 4885-4907. https://doi.org/10.1002/ptr.7955
Vancouver
Zhang Q, Jiang Q, Sa K, Liang J, Sun D, Li H, et al. Research progress of plant‐derived natural alkaloids in central nervous system diseases. Phytotherapy Research. 2023;37(11):4885-4907. doi:10.1002/ptr.7955
BibTeX
@article{Zhang2023,
author = {Zhang, Qingqing and Jiang, Qinghua and Sa, Kuiru and Liang, Junming and Sun, Dejuan and Li, Hua and Chen, Lixia},
title = {Research progress of plant‐derived natural alkaloids in central nervous system diseases},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {11},
pages = {4885--4907},
doi = {10.1002/ptr.7955}
}
EUVIMED